NRC Health Payments of Debt Issuance Costs
NRC Health (NRC) reported Payments of Debt Issuance Costs of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2026-08-04
- NRC Health payments of debt issuance costs for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- NRC Health payments of debt issuance costs for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- NRC Health payments of debt issuance costs for the quarter ending 2025-12-31 was -$1.00K, a 120.00% decline year-over-year.
- NRC Health payments of debt issuance costs for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- NRC Health payments of debt issuance costs for fiscal 2025 was $134.00K, a 219.05% increase from fiscal 2024.
- NRC Health payments of debt issuance costs for fiscal 2024 was $42.00K, a 425.00% increase from fiscal 2023.
- NRC Health payments of debt issuance costs for fiscal 2023 was $8.00K, a 91.30% decline from fiscal 2022.
- NRC Health payments of debt issuance costs for fiscal 2022 was $92.00K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $0.00 10-Q · filed 2026-08-04 | -$1.00K derived: sum of 3 quarters · filed 2026-08-04 | -$1.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 | -$1.00K derived: sum of 2 quarters · filed 2026-05-06 | -$1.00K derived: sum of 3 quarters · filed 2026-05-06 | $72.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$1.00K derived: sum of 2 quarters · filed 2026-03-05 | $72.00K derived: sum of 3 quarters · filed 2026-08-04 | $134.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $73.00K derived: sum of 2 quarters · filed 2026-08-04 | $135.00K 10-Q · filed 2025-11-07 | $140.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $73.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $135.00K 10-Q · filed 2026-08-04 | $140.00K derived: sum of 3 quarters · filed 2026-08-04 | $177.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $62.00K 10-Q · filed 2026-05-06 | $67.00K derived: sum of 2 quarters · filed 2026-05-06 | $104.00K derived: sum of 3 quarters · filed 2026-05-06 | $104.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $42.00K derived: sum of 2 quarters · filed 2026-03-05 | $42.00K derived: sum of 3 quarters · filed 2026-03-05 | $42.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $37.00K derived: sum of 2 quarters · filed 2025-11-07 | $37.00K 10-Q · filed 2025-11-07 | $37.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | $0.00 derived: sum of 3 quarters · filed 2026-03-05 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-09 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $8.00K 10-K · filed 2026-03-05 | ||
| 2023-09-30 | $8.00K 10-Q · filed 2024-11-08 | |||
| 2022-12-31 | $92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $92.00K 10-K · filed 2025-03-17 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 | ||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-05 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $36.00K 10-K · filed 2023-03-03 | ||
| 2020-09-30 | $36.00K 10-Q · filed 2021-11-05 | |||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-06 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $0.00 derived: sum of 2 quarters · filed 2021-03-05 | $187.00K 10-K · filed 2021-03-05 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $187.00K 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | $187.00K 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |